Skip to main content

Advertisement

SpringerLink
Log in

Sleep Apnea and Skin

  • Sleep and Sleep Apnea at the Extremes (D Gozal, Section Editor)
  • Published:
Current Sleep Medicine Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

Skin disease is associated with obstructive sleep apnea (OSA) both epidemiologically and mechanistically. In this review, we highlight conditions which have a well-established link to obstructive sleep apnea, such as psoriasis and atopic dermatitis.

Recent Findings

We describe putative mechanistic links between OSA and skin disease involving inflammatory pathways, obesity, mechanical upper airways obstruction, and hypoxia. In the context of these mechanisms, we describe specific skin conditions, and other conditions which are associated with both skin manifestations (including hair/nail findings) and OSA. The risks/benefits of CPAP in the context of skin disease are also reviewed.

Summary

We conclude that further research is needed to understand the mechanisms behind the associations between OSA and skin disease. Given the frequent co-occurrence of OSA and skin conditions, there would be great benefit for OSA clinical trials to consider improvement in skin disease as an outcome measure.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Chervin RD, Ruzicka DL, Vahabzadeh A, Burns MC, Burns JW, Buchman SR. The face of sleepiness: improvement in appearance after treatment of sleep apnea. Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine. 2013;9(9):845–52.

    Google Scholar 

  2. Jennum P, Ibsen R, Kjellberg J. Morbidity prior to a diagnosis of sleep-disordered breathing: a controlled national study. Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine. 2013;9(2):103–8.

    Google Scholar 

  3. Jennum P, Ibsen R, Kjellberg J. Morbidity and mortality in children with obstructive sleep apnoea: a controlled national study. Thorax. 2013;68(10):949–54.

    PubMed  Google Scholar 

  4. Hirotsu C, Nogueira H, Albuquerque RG, Tomimori J, Tufik S, Andersen ML. The bidirectional interactions between psoriasis and obstructive sleep apnea. Int J Dermatol. 2015;54(12):1352–8.

    PubMed  Google Scholar 

  5. Gupta MA, Simpson FC, Vujcic B, Gupta AK. Obstructive sleep apnea and dermatologic disorders. Clin Dermatol. 2017;35(3):319–27.

    PubMed  Google Scholar 

  6. • Gabryelska A, Sochal M, Wasik B, Białasiewicz P. Patients with obstructive sleep apnea are over four times more likely to suffer from psoriasis than the general population. Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine. 2018;14(1):153 Several epidemiologic studies have demonstrated the association between OSA and psoriasis. This is the most recent study to add to that literature; this letter to the editor found psoriasis in 8.7% of 245 OSA patients (AHI > 5) undergoing PSG.

    Google Scholar 

  7. Yang YW, Kang JH, Lin HC. Increased risk of psoriasis following obstructive sleep apnea: a longitudinal population-based study. Sleep Med. 2012;13(3):285–9.

    PubMed  Google Scholar 

  8. Papadavid E, Dalamaga M, Vlami K, Koumaki D, Gyftopoulos S, Christodoulatos GS, et al. Psoriasis is associated with risk of obstructive sleep apnea independently from metabolic parameters and other comorbidities: a large hospital-based case-control study. Sleep Breath. 2017;21(4):949–58.

    PubMed  Google Scholar 

  9. Karaca S, Fidan F, Erkan F, Nural S, Pinarcı T, Gunay E, et al. Might psoriasis be a risk factor for obstructive sleep apnea syndrome? Sleep Breath. 2013;17(1):275–80.

    PubMed  Google Scholar 

  10. Kabeloglu Ilbay V, Tas B, Altuntas M, Atakli HD, Soysal A. Risk of obstructive sleep apnea syndrome in psoriasis patients. Arch Iran Med. 2019;22(3):137–43.

    PubMed  Google Scholar 

  11. Papadavid E, Vlami K, Dalamaga M, Giatrakou S, Theodoropoulos K, Gyftopoulos S, et al. Sleep apnea as a comorbidity in obese psoriasis patients: a cross-sectional study. Do psoriasis characteristics and metabolic parameters play a role? J Eur Acad Dermatol Venereol. 2013;27(7):820–6.

    PubMed  CAS  Google Scholar 

  12. Fishbein AB, Sheldon S, Grimaldi D. Author response. Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine. 2020;16(3):465.

    Google Scholar 

  13. Gupta MA, Simpson FC, Gupta AK. Psoriasis and sleep disorders: a systematic review. Sleep Med Rev. 2016;29:63–75.

    PubMed  Google Scholar 

  14. Saçmacı H, Gürel G. Sleep disorders in patients with psoriasis: a cross-sectional study using non-polysomnographical methods. Sleep Breath. 2019;23(3):893–8.

    PubMed  Google Scholar 

  15. Gabryelska A, Białasiewicz P. Is autonomic activation a middleman between obstructive sleep apnea syndrome and psoriasis? Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine. 2018;14(6):1087–8.

    Google Scholar 

  16. Gowda S, Goldblum OM, McCall WV, Feldman SR. Factors affecting sleep quality in patients with psoriasis. J Am Acad Dermatol. 2010;63(1):114–23.

    PubMed  Google Scholar 

  17. Maari C, Bolduc C, Nigen S, Marchessault P, Bissonnette R. Effect of adalimumab on sleep parameters in patients with psoriasis and obstructive sleep apnea: a randomized controlled trial. J Dermatol Treat. 2014;25(1):57–60.

    CAS  Google Scholar 

  18. Fishbein AB, Vitaterna O, Haugh IM, Bavishi AA, Zee PC, Turek FW, et al. Nocturnal eczema: review of sleep and circadian rhythms in children with atopic dermatitis and future research directions. J Allergy Clin Immunol. 2015;136(5):1170–7.

    PubMed  Google Scholar 

  19. Fishbein AB, Mueller K, Kruse L, Boor P, Sheldon S, Zee P, et al. Sleep disturbance in children with moderate/severe atopic dermatitis: a case-control study. J Am Acad Dermatol. 2018;78(2):336–41.

    PubMed  Google Scholar 

  20. Treister AD, Stefek H, Grimaldi D, Rupani N, Zee P, Yob J, et al. Sleep and limb movement characteristics of children with atopic dermatitis coincidentally undergoing clinical polysomnography. Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine. 2019;15(8):1107–13.

    Google Scholar 

  21. Tien KJ, Chou CW, Lee SY, Yeh NC, Yang CY, Yen FC, et al. Obstructive sleep apnea and the risk of atopic dermatitis: a population-based case control study. PLoS One. 2014;9(2):e89656.

    PubMed  PubMed Central  Google Scholar 

  22. • Hu JM, Lin CS, Chen SJ, Chen CY, Lin CL, Kao CH. Association between obstructive sleep apnea and atopic dermatitis in children: a nationwide, population-based cohort study. Pediatr Allergy Immunol. 2018;29(3):260–6 This is the most recent epidemiologic publication linking atopic dermatitis with OSA, and to our knowledge the largest pediatric cohort study including 120,736 AD patients and 120,736 age-/gender-matched controls. They found atopic dermatitis patients have a 1.86-fold risk of OSA.

    PubMed  Google Scholar 

  23. Alexopoulos EI, Bizakis J, Gourgoulianis K, Kaditis AG. Atopy does not affect the frequency of adenotonsillar hypertrophy and sleep apnoea in children who snore. Acta Paediatr (Oslo, Norway : 1992). 2014;103(12):1239–43.

    Google Scholar 

  24. Huo Z, Shi J, Shu Y, Xiang M, Lu J, Wu H. The relationship between allergic status and adenotonsillar regrowth: a retrospective research on children after adenotonsillectomy. Sci Rep. 2017;7:46615.

    PubMed  PubMed Central  CAS  Google Scholar 

  25. Nagaya T, Kawata K, Kamekura R, Jitsukawa S, Kubo T, Kamei M, et al. Lipid mediators foster the differentiation of T follicular helper cells. Immunol Lett. 2017;181:51–7.

    PubMed  CAS  Google Scholar 

  26. Paulucci BP, Pereira J, Picciarelli P, Levy D, Di Francesco RC. Expression of cysteinyl leukotriene receptor 1 and 2 (CysLTR1 and CysLTR2) in the lymphocytes of hyperplastic tonsils: comparison between allergic and nonallergic snoring children. Int Forum Allergy Rhinol. 2016;6(11):1151–8.

    PubMed  Google Scholar 

  27. Kheirandish-Gozal L, Bandla HP, Gozal D. Montelukast for children with obstructive sleep apnea: results of a double-blind, randomized, Placebo-Controlled Trial. Ann Am Thorac Soc. 2016;13(10):1736–41.

    PubMed  PubMed Central  Google Scholar 

  28. Dayyat E, Serpero LD, Kheirandish-Gozal L, Goldman JL, Snow A, Bhattacharjee R, et al. Leukotriene pathways and in vitro adenotonsillar cell proliferation in children with obstructive sleep apnea. Chest. 2009;135(5):1142–9.

    PubMed  CAS  Google Scholar 

  29. Silverberg JI, Becker L, Kwasny M, Menter A, Cordoro KM, Paller AS. Central obesity and high blood pressure in pediatric patients with atopic dermatitis. JAMA Dermatol. 2015;151(2):144–52.

    PubMed  Google Scholar 

  30. Silverberg JI, Silverberg NB, Lee-Wong M. Association between atopic dermatitis and obesity in adulthood. Br J Dermatol. 2012;166(3):498–504.

    PubMed  CAS  Google Scholar 

  31. •• Fishbein AB, Lor J, Penedo FJ, Forrest CB, Griffith JW, Paller AS. Patient-Reported Outcomes for Measuring Sleep Disturbance in Pediatric Atopic Dermatitis: cross sectional study of PROMIS Pediatric Sleep Measures and Actigraphy. Journal of the American Academy of Dermatology. 2020; This is the first study to present an evidence-based algorithm for assessing sleep in children with atopic dermatitis, first by screening with patient/parent-reported measures and then objective sleep assessment as needed.

  32. Tahrani AA, Ali A, Raymond NT, Begum S, Dubb K, Mughal S, et al. Obstructive sleep apnea and diabetic neuropathy: a novel association in patients with type 2 diabetes. Am J Respir Crit Care Med. 2012;186(5):434–41.

    PubMed  PubMed Central  Google Scholar 

  33. Altaf QA, Ali A, Piya MK, Raymond NT, Tahrani AA. The relationship between obstructive sleep apnea and intra-epidermal nerve fiber density, PARP activation and foot ulceration in patients with type 2 diabetes. J Diabetes Complicat. 2016;30(7):1315–20.

    PubMed  Google Scholar 

  34. Vas PR, Ahluwalia R, Manas AB, Manu CA, Kavarthapu V, Edmonds ME. Undiagnosed severe sleep apnoea and diabetic foot ulceration - a case series based hypothesis: a hitherto under emphasized factor in failure to heal. Diabetic medicine : a journal of the British Diabetic Association. 2016;33(2):e1–4.

    CAS  Google Scholar 

  35. Wertenteil S, Strunk A, Garg A. Incidence of obstructive sleep apnoea in patients with hidradenitis suppurativa: a retrospective population-based cohort analysis. Br J Dermatol. 2018;179(6):1398–9.

    PubMed  CAS  Google Scholar 

  36. Setji TL, Brown AJ. Polycystic ovary syndrome: diagnosis and treatment. Am J Med. 2007;120(2):128–32.

    PubMed  Google Scholar 

  37. Hoppin AG, Katz ES, Kaplan LM, Lauwers GY. Case records of the Massachusetts General Hospital. Case 31-2006. A 15-year-old girl with severe obesity. N Engl J Med. 2006;355(15):1593–602.

    PubMed  CAS  Google Scholar 

  38. Buyuktas D, Arslan E, Celik O, Tasan E, Demirkesen C, Gundogdu S. Elephantiasis nostras verrucosa on the abdomen of a Turkish female patient caused by morbid obesity. Dermatol Online J. 2010;16(8):14.

    PubMed  CAS  Google Scholar 

  39. Shanmugam VK, Tsagaris KC, Attinger CE. Leg ulcers associated with Klinefelter's syndrome: a case report and review of the literature. Int Wound J. 2012;9(1):104–7.

    PubMed  Google Scholar 

  40. Hegele RA, Al-Attar SA, Rutt BK. Obstructive sleep apnea in 2 women with familial partial lipodystrophy due to a heterozygous LMNA R482Q mutation. Cmaj. 2007;177(7):743–5.

    PubMed  PubMed Central  Google Scholar 

  41. Carr A, Cooper DA. Adverse effects of antiretroviral therapy. Lancet. 2000;356(9239):1423–30.

    PubMed  CAS  Google Scholar 

  42. Epstein LJ, Strollo PJ Jr, Donegan RB, Delmar J, Hendrix C, Westbrook PR. Obstructive sleep apnea in patients with human immunodeficiency virus (HIV) disease. Sleep. 1995;18(5):368–76.

    PubMed  CAS  Google Scholar 

  43. Harsch IA, Bergmann T, Koebnick C, Wiedmann R, Ruderich F, Hahn EG, et al. Adiponectin, resistin and subclinical inflammation--the metabolic burden in Launois Bensaude syndrome, a rare form of obesity. Journal of physiology and pharmacology : an official journal of the Polish Physiological Society. 2007;58(Suppl 1):65–76.

    Google Scholar 

  44. Hanson RD, Olsen KD, Rogers RS 3rd. Upper aerodigestive tract manifestations of cicatricial pemphigoid. Ann Otol Rhinol Laryngol. 1988;97(5 Pt 1):493–9.

    PubMed  CAS  Google Scholar 

  45. Gozal D, Ham SA, Mokhlesi B. Sleep apnea and cancer: analysis of a nationwide population sample. Sleep. 2016;39(8):1493–500.

    PubMed  PubMed Central  Google Scholar 

  46. Santamaria-Martos F, Benítez I, Girón C, Barbé F, Martínez-García MA, Hernández L, et al. Biomarkers of carcinogenesis and tumour growth in patients with cutaneous melanoma and obstructive sleep apnoea. Eur Respir J. 2018;51(3).

  47. Almendros I, Martínez-García M, Campos-Rodríguez F, Riveiro-Falkenbach E, Rodríguez-Peralto JL, Nagore E, et al. Intermittent hypoxia is associated with high hypoxia inducible factor-1α but not high vascular endothelial growth factor cell expression in tumors of cutaneous melanoma patients. Front Neurol. 2018;9:272.

    PubMed  PubMed Central  Google Scholar 

  48. •• Martinez-Garcia MA, Campos-Rodriguez F, Nagore E, Martorell A, Rodriguez-Peralto JL, Riveiro-Falkenbach E, et al. Sleep-disordered breathing is independently associated with increased aggressiveness of cutaneous melanoma: a multicenter OBSERVATIONAL STUDY in 443 patients. Chest. 2018;154(6):1348–58 First study to show SDB is associated with melanoma aggressiveness. This well-designed study of 443 melanoma patients evaluated objective sleep disordered breathing measures (such as AHI) and patient-reported measures to demonstrate the association of SDB and several markers of melanoma aggressiveness (i.e. ulceration, sentinel lymph noted spread, etc). There was a “severity dependent” effect of AHI on tumor staging.

    PubMed  Google Scholar 

  49. Martinez-Garcia MA, Campos-Rodriguez F, Almendros I, Garcia-Rio F, Sanchez-de-la-Torre M, Farre R, et al. Cancer and sleep apnea: cutaneous melanoma as a case study. Am J Respir Crit Care Med. 2019;200(11):1345–53.

    PubMed  CAS  Google Scholar 

  50. Baik I, Lee S, Thomas RJ, Shin C. Obstructive sleep apnea, low transferrin saturation levels, and male-pattern baldness. Int J Dermatol. 2019;58(1):67–74.

    PubMed  Google Scholar 

  51. Pépin JL, Leger P, Veale D, Langevin B, Robert D, Lévy P. Side effects of nasal continuous positive airway pressure in sleep apnea syndrome. Study of 193 patients in two French sleep centers. Chest. 1995;107(2):375–81.

    PubMed  Google Scholar 

  52. Matin A, Bliwise DL, Wellman JJ, Ewing HA, Rasmuson P. Resolution of dyshidrotic dermatitis of the hand after treatment with continuous positive airway pressure for obstructive sleep apnea. South Med J. 2002;95(2):253–4.

    PubMed  Google Scholar 

  53. Nino G, Singareddy R. Severe onychophagia and finger mutilation associated with obstructive sleep apnea. Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine. 2013;9(4):379–81.

    Google Scholar 

Download references

Acknowledgments

The authors would like to acknowledge Ms. Andrea Fawcett for her help in the literature review.

Author information

Authors and Affiliations

  1. Department of Internal Medicine, University of Illinois at Chicago, Chicago, IL, USA

    Vinaya Soundararajan & Jennifer Lor

  2. Department of Allergy, Division of Pediatric Allergy & Immunology, Ann & Robert H. Lurie Children’s Hospital of Chicago, Northwestern University, 225 E. Chicago Avenue #60, Chicago, IL, 60611, USA

    Jennifer Lor & Anna B. Fishbein

Authors
  1. Vinaya Soundararajan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jennifer Lor
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Anna B. Fishbein
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Anna B. Fishbein.

Ethics declarations

Conflict of Interest

Dr. Fishbein has grant support from Pfizer and served as consultant for Regeneron. Dr. Fishbein also has grant support from NIH.

Human and Animal Rights

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Sleep and Sleep Apnea at the Extremes

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Soundararajan, V., Lor, J. & Fishbein, A.B. Sleep Apnea and Skin. Curr Sleep Medicine Rep 6, 94–100 (2020). https://doi.org/10.1007/s40675-020-00179-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40675-020-00179-7

Keywords

Search

Navigation